Feedback / Questions
AGX101 - Angiex
https://www.globenewswire.com/news-release/2025/11/17/3189085/0/en/Angiex-Completes-Financings-Totaling-31-Million-to-Advance-Phase-1-Dose-Escalation-of-Nuclear-Delivered-ADC-AGX101-in-Patients-with-Advanced-Solid-Tumors.html
Nov 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next